Hydroxychloroquine Sulfate Tablet shortage
Hydroxychloroquine Sulfate Tablet is currently listed in shortage by the FDA. The FDA lists 1 affected product. This page was last refreshed from FDA data on Oct 2, 2026.
Teva is permanently stopping its hydroxychloroquine sulfate 200 mg tablets. Other makers — including Major Pharmaceuticals, Rising Pharma, Northstar Rx, and Accord Healthcare — still list this medicine as available.
Don’t stop or change your therapy on your own — talk with your prescriber about the plan that fits you, and ask your pharmacist what’s actually available (see options).
Do you take this drug? See the ‘What to do’ recommendation from Dr. Brian Staiger, PharmD →What’s in shortage — at a glance
These figures count only the manufacturers that reported this shortage to the FDA — not every company that makes Hydroxychloroquine Sulfate Tablet. Other makers that haven’t reported a problem are shown in the green card below.
Shortage timeline
-
Jan 5, 2026Currently in shortage1 of 1 product affected.
-
Jan 5, 2026First reported to the FDA1 product first listed.
Built from FDA posting and update dates. The end date FDA publishes is the posting/update date, not a true resolution date, so durations are approximate.
What exactly is on backorder — by manufacturer
Manufacturer: Teva Pharmaceuticals USA, Inc. 📞 800-545-8800 1 NDC click to expand
| Status | NDC / product | Strength | Availability | Related information | Reason |
|---|---|---|---|---|---|
| To Be Discontinued | Hydroxychloroquine Sulfate, Tablet, 200 mg (NDC 0093-2401-01) | — | — | Discontinuation of the manufacture of the drug | — |
These rows are manufacturer reports to the FDA for Hydroxychloroquine Sulfate Tablet — they do not necessarily cover every manufacturer that makes this drug. A company appears here only if it told the FDA it has a supply problem, so other makers may still have stock. That’s the basis for the Where else can I get Hydroxychloroquine Sulfate Tablet? options further down this page.
Why is Hydroxychloroquine Sulfate Tablet in shortage?
Teva Pharmaceuticals has reported to the FDA that they are permanently stopping the manufacturing of their 200 mg hydroxychloroquine sulfate tablets (the specific package with NDC 0093-2401-01). This means that particular version of the tablet made by Teva will no longer be produced going forward.
It's worth knowing that Teva did not share a specific public reason for why they made this decision — just that they are discontinuing the manufacture of this product. Also, keep in mind that this report only covers Teva's version of this medication, so it doesn't speak to what other manufacturers may be doing with their own supplies of hydroxychloroquine.
Based on the manufacturer-reported reason(s) and notes on file with the FDA for Hydroxychloroquine Sulfate Tablet, summarized in plain English by HelloPharmacist. A drug can be short for more than one reason, and the FDA updates these as manufacturers report changes.
What should I do if I take Hydroxychloroquine Sulfate Tablet?
Hydroxychloroquine Sulfate 200 mg tablets are currently on the FDA drug-shortage list. This note is meant to help you understand what that means and what steps make sense next.
The record here involves the 200 mg tablet, and it shows no available source from the manufacturer that filed this report (Teva Pharmaceuticals). The reason given is that Teva is discontinuing its production of this tablet. Because this is a discontinuation rather than a temporary delay, this particular supply may not return. Importantly, though, this report reflects only one manufacturer — other companies still make hydroxychloroquine sulfate 200 mg, so the medicine itself remains on the market.
Please do not stop, skip, or change your dose on your own. Here are the steps I'd suggest:
- Ask your pharmacy to check wholesalers and other makers; the same 200 mg tablet is listed as available from other manufacturers, including Major Pharmaceuticals, Rising Pharma, Northstar Rx, Accord Healthcare, Dr. Reddy's, and A-S Medication Solutions — though these may not be in your local stock right away.
- If your pharmacy cannot source the 200 mg tablet, ask your prescriber or pharmacist about options, such as a different strength to make up your dose or another clinician-chosen choice.
- Manufacturer contact numbers are listed on this page for reference, though pharmacies usually handle those calls.
This is general national information and may not match your local pharmacy's actual stock.
- Don’t stop or change the medication on your own — talk to your prescriber first.
- If this is part of an ongoing or essential regimen (for example HIV treatment or prevention, seizure, heart, transplant, diabetes or mental-health medicines), do not skip or ration doses — contact your pharmacist or prescriber right away to arrange continued supply before you run out.
- Ask your pharmacy to check other manufacturers, strengths, package sizes, and nearby stores.
- Ask your prescriber whether a different strength, formulation, or the brand/generic version is appropriate.
Uses, dosing, side effects, prices, and the complete FDA label — written in plain English and pharmacist-reviewed.
Where else can I get Hydroxychloroquine Sulfate Tablet?
FDA shortages are manufacturer-reported — a company only shows up on the shortage list if it told the FDA it has a supply problem, so not every maker of Hydroxychloroquine Sulfate Tablet is necessarily short. Below we pull together the other still-marketed options that are not reported in shortage: the same medicine from manufacturers that haven’t reported a problem, and alternative dosage forms. These may still be out of stock at your pharmacy, and only your prescriber or pharmacist can decide what’s right for you.
Same medicine, other manufacturers (not reported short)
Same active ingredient, dosage form & route as the shortage (matched on the FDB HICL ingredient code), from makers that have not filed a shortage with the FDA:
| Product | Strength | Form / route | Manufacturer | NDC |
|---|---|---|---|---|
| Hydroxychloroquine Sulfate | HYDROXYCHLOROQUINE SULFATE 200 mg/1 | Tablet, Film Coated · Oral | Major Pharmaceuticals | 00904-7046-06 |
| Hydroxychloroquine Sulfate | HYDROXYCHLOROQUINE SULFATE 200 mg/1 | Tablet, Film Coated · Oral | Rising Pharma Holdings, Inc. | 16571-0112-01 |
| Hydroxychloroquine Sulfate | HYDROXYCHLOROQUINE SULFATE 200 mg/1 | Tablet, Film Coated · Oral | Northstar Rx LLC. | 16714-0110-01 |
| Hydroxychloroquine Sulfate | HYDROXYCHLOROQUINE SULFATE 200 mg/1 | Tablet · Oral | Accord Healthcare, Inc., | 16729-0485-01 |
| Hydroxychloroquine Sulfate | HYDROXYCHLOROQUINE SULFATE 100 mg/1 | Tablet · Oral | Accord Healthcare, Inc., | 16729-0561-01 |
| Hydroxychloroquine Sulfate | HYDROXYCHLOROQUINE SULFATE 300 mg/1 | Tablet · Oral | Accord Healthcare, Inc., | 16729-0562-01 |
| Hydroxychloroquine Sulfate | HYDROXYCHLOROQUINE SULFATE 400 mg/1 | Tablet · Oral | Accord Healthcare, Inc., | 16729-0563-01 |
| Hydroxychloroquine Sulfate | HYDROXYCHLOROQUINE SULFATE 400 mg/1 | Tablet, Film Coated · Oral | Dr. Reddy's Laboratories Inc. | 43598-0131-01 |
| Hydroxychloroquine Sulfate | HYDROXYCHLOROQUINE SULFATE 300 mg/1 | Tablet, Film Coated · Oral | Dr. Reddy's Laboratories Inc. | 43598-0132-01 |
| Hydroxychloroquine Sulfate | HYDROXYCHLOROQUINE SULFATE 100 mg/1 | Tablet, Film Coated · Oral | Dr. Reddy's Laboratories Inc. | 43598-0133-01 |
| Hydroxychloroquine Sulfate | HYDROXYCHLOROQUINE SULFATE 200 mg/1 | Tablet, Film Coated · Oral | Dr. Reddy's Laboratories Inc. | 43598-0721-01 |
| Hydroxychloroquine Sulfate | HYDROXYCHLOROQUINE SULFATE 200 mg/1 | Tablet, Film Coated · Oral | A-S Medication Solutions | 50090-4659-01 |
Therapeutic equivalents & pricing 30 productsclick to expand
Orange Book–rated equivalents of the affected strengths, with the latest NADAC price (a federal retail-acquisition benchmark, not your copay) and an evidence-based availability label. Cheapest first.
| Product | Manufacturer | Package | NADAC $/unit | AB rating | Availability |
|---|---|---|---|---|---|
| Hydroxychloroquine Sulfate 200 mg | Teva | 100 tablets | $0.149 | AB | Availability likely |
| Hydroxychloroquine Sulfate 200 mg | Major | 50 tablets | $0.149 | AB | Availability likely |
| Hydroxychloroquine Sulfate 200 mg | Rising | 100 tablets | $0.149 | AB | Availability likely |
| Hydroxychloroquine sulfate 200 mg | Northstar | 100 tablets | $0.149 | AB | Availability likely |
| Hydroxychloroquine Sulfate 200 mg | Accord | 100 tablets | $0.149 | AB | Availability likely |
| Hydroxychloroquine Sulfate 200 mg | Dr. | 100 tablets | $0.149 | AB | Availability likely |
| Hydroxychloroquine Sulfate 200 mg | AvPAK | 50 tablets | $0.149 | AB | Availability likely |
| Hydroxychloroquine Sulfate 200 mg | Aurobindo | 100 tablets | $0.149 | AB | Availability likely |
| Hydroxychloroquine 200 mg | Chartwell | 90 tablets | $0.149 | AB | Availability likely |
| Hydroxychloroquine Sulfate 200 mg | American | 1 tablet | $0.149 | AB | Availability likely |
| Hydroxychloroquine sulfate 200 mg | Zydus | 100 tablets | $0.149 | AB | Availability likely |
| Hydroxychloroquine Sulfate 200 mg | Amneal | 100 tablets | $0.149 | AB | Availability likely |
| Hydroxychloroquine sulfate 200 mg | Quallent | 500 tablets | $0.149 | AB | Availability likely |
| Hydroxychloroquine Sulfate 200 mg | Ipca | 100 tablets | $0.149 | AB | Availability likely |
| Hydroxychloroquine sulfate 200 mg | Sun | 500 tablets | $0.176 | AB | FDA listed |
| Hydroxychloroquine sulfate 200 mg | NCS | 30 tablets | — | AB | FDA listed |
| Hydroxychloroquine Sulfate 200 mg | Laurus | 100 tablets | — | AB | FDA listed |
| Hydroxychloroquine Sulfate 200 mg | A-S | 60 tablets | — | AB | Discontinued |
| Hydroxychloroquine sulfate 200 mg | A-S | 30 tablets | — | AB | Discontinued |
| Hydroxychloroquine Sulfate 200 mg | A-S | 60 tablets | — | AB | FDA listed |
| Hydroxychloroquine sulfate 200 mg | A-S | 90 tablets | — | AB | FDA listed |
| Hydroxychloroquine sulfate 200 mg | A-S | 60 tablets | — | AB | FDA listed |
| Hydroxychloroquine sulfate 200 mg | A-S | 90 tablets | — | AB | FDA listed |
| Hydroxychloroquine sulfate 200 mg | Cardinal | 1 tablet | — | AB | FDA listed |
| Hydroxychloroquine Sulfate 200 mg | Cardinal | 10 tablets | — | AB | FDA listed |
| Plaquenil 200 mg | Advanz | 100 tablets | — | AB | FDA listed |
| Hydroxychloroquine Sulfate 200 mg | Amneal | 100 tablets | — | AB | FDA listed |
| Hydroxychloroquine sulfate 200 mg | Zydus | 100 tablets | — | AB | FDA listed |
| Hydroxychloroquine Sulfate 200 mg | Coupler | 30 tablets | — | AB | FDA listed |
| Hydroxychloroquine sulfate 200 mg | NuCare | 100 tablets | — | AB | FDA listed |
Equivalents share the same ingredient, strength, dosage form and route; an AB rating means the FDA considers them substitutable. NADAC is a national retail-pharmacy acquisition benchmark from CMS — not what you pay. Availability is inferred from recent pricing, not a stock check.
Other drugs in the same treatment class
These are different medicines — not other versions of Hydroxychloroquine Sulfate Tablet — that fall in the same broad treatment class (antimalarial drugs) . They are not automatic substitutes: they can differ in how they work, dosing, effectiveness, side effects and what they’re approved to treat. Do not switch on your own. This list is for information only — ask your prescriber or pharmacist whether any of them is appropriate for you.
Identity & classification
Where does this data come from?
Hydroxychloroquine Sulfate Tablet shortage FAQs
Is Hydroxychloroquine Sulfate Tablet in shortage?
Which products are affected?
When will Hydroxychloroquine Sulfate Tablet be available again?
Can I still get Hydroxychloroquine Sulfate somewhere?
What should I do if I take Hydroxychloroquine Sulfate Tablet?
Still have a question about the Hydroxychloroquine Sulfate Tablet shortage?
Ask a pharmacist about this shortage →View Hydroxychloroquine Sulfate Tablet on the FDA drug-shortage database →
Where does this data come from?
/drug/shortages) — drug, manufacturer & contact, NDC/product, status, availability, reason, therapeutic category and posting/update dates. Current / To Be Discontinued = active; Resolved is kept for history. The Supply-Risk rating is assessed per active ingredient and adds the FDA NDC Directory (still-marketed manufacturers by ingredient & form); same-medicine and equivalent products use First Databank classification + CMS NADAC pricing; Medicaid use + most-affected states come from CMS Medicaid State Drug Utilization Data. Reference only — confirm current status with the manufacturer or FDA before acting on it.